44 Pharmaceutical Technology
®
Regulating Innovation, Quality, and Risk eBook January 2024 PharmTech.com
Qualit
y
69. Woodcock, J. PDA J Pharm Sci Technol. online (May/
June 2012), DOI: 10.5731/pdajpst.2012.00874.
70. FDA. Drug Shortages: Root Causes and Potential Solu-
tions (2020). https://www.fda.gov/media/131130/
download
71. American Society for Quality. (n.d.). Qualit y Re-
sources: Cost of Quality (COQ). ASQ. https://asq.org/
quality-resources/cost-of-quality
72. Patel, P.; Baker, D.; Burdick, R.; Chen, C.; Hill, J.;
Holland, M.; and Sawant, A. Quality Culture Sur-
vey Report. PDA Journal of Pharmaceutical Science
and Technology, 2015 69(5), 631-642. https://doi.
org/10.5731/pdajpst.2015.01078
73. Gieske, H.; Buu ren , A. V.; Bek kers, V. J. J. M.
Conceptualizing Public Innovative Capacit y: A
Framework for Assessment. Innovation Journal,
2016. 21(1).(accessed July 13, 2021), https://www.re-
searchgate.net/publication/302900973_Concep-
tualizing _ public_innovative_capacity _A_frame-
work_for_assessment
74. Lee, S. M. and Trimi, S. Innovation for Creating
a Sma r t Fut u re. Jour nal of Innovat ion & Knowl-
edge, 2018. 3(1), 1-8. ht t ps://doi.org/10.1016/j.
jik.2016.11.001
75. Kramer, M. R. and Pfitzer, M. W. Ecosystems of
Shared Value. Harvard Business Review, 2016. 80-
89. ht t ps:// hbr.org/2016/10/t he-ecos ystem-of-
shared-value
76. D e d e h ay i r, O.; O r t t , R . J.; R i ve r ol a , C .; a n d
M i r a l les, F. C h apter 4: I n nov ator s a nd E a rly
Adopters in the Diff usion of Innovations: A Lit-
erat ure Rev iew. Inter national Jour nal of Innova-
t ion Management , 2019 21(8), 1-27. ht t ps://doi.
org/10.1142/9781786347602_0004
77. Dorn, E.J.; Frantz, J. J.; and Valerio, P. F. 2020 ISPE
Barrier Sur vey: Tracking the Journey of Barrier
Technology. ispe.org, July/August 2020.
78. Rogers, E. M. Diffusion of Innovations (Free Press,
New York, 5th ed., 2003).
79. Perrow, C. Bulletin of the Atomic Scientists. online,
(Nov. 27, 2015). DOI: 10.1177/0096340211426395.
80. P fat teicher, S. K. A. Jour nal of Per for mance of
C o n s t r u c t e d F a c ilit i e s . on l i n e , D OI: 10.10 61/
(ASCE)0887-.May 1, 2000 3828(2000)14:2(62).
81. Page, T.; Dubina, H.; Fillipi, G.; Guidat, R.; Patnaik,
S.; Poechlauer, P.; Shering, P.; Guinn, M.; Mcdon-
nell, P.; and Johnston, C. Equipment and Analyt-
ical Companies Meeting Continuous Challenges.
May 20–21, 2014 Continuous Manufacturing Sym-
posium. Journal of Pharmaceutical Sciences, 2015.
104(3), 821-831. https://doi.org/10.1002/jps.24282
82. Szymczak, M. M.; Friedman, R. L.; Uppoor, R.; and
Yacobi, A. Detection, Measurement, and Control
in Pharma Manufacturing: PQRI-FDA Workshop
Summar y on Process Drift. Pharmaceutical Tech-
nology, 2011. 70-76. (accessed July 13, 2021). https://
pqri.org/wp-content/uploads/2015/08/pdf/Pro-
cessDrift-Final-article.pdf
83. ICH. ICH Q9 EWG Training Slides: Availability. ich.
org.
84. Crosby, P.B. Quality Is Free: The Art of Making Qual-
ity Certain (1
st
ed.). McGraw-Hill. (1979).
85. Friedli, T.; Kickuth, M.; Stieneker, F.; Thaler, P.;
and Werani, J. Operational Excellence in the Phar-
maceutical Industr y (1
st
ed.). Editio Cantor Verlag.
(2016).
86. Davis, J. R. and Atkinson, T. Need Speed? Slow
Down. Harvard Business Review. 2010. https://hbr.
org/2010/05/need-speed-slow-down
87. Miller, O. W.; Chou, Kuo-Chong; Chang, C. Alec
Case Study: Use of the Taguchi Loss Function (1989,
ASQC).
88. Paulk, M.C.; Weber, C. V.; Curtis, B.; and Chrissis,
M., B. The Capability Maturity Model: Guidelines
for Improving the Software Process (1
st
ed.). Carne-
gie Mellon University Software Engineering Insti-
tute, Addison-Wesley Professional. (1994).
89. McK i n sey & Compa ny. F lawless: From measur-
ing failure to building quality robustness in pharma.
McKinsey & Company. Feb. 1, 2015. https://www.
mckinsey.com/~/media/mckinsey/dotcom/client_
service/operations/pdfs/f lawless_from_measur-
ing _failure_to_building _quality _robustness_in_
pharma_intro_chapter.ashx
90. Schiffauerova, A. and Thomson, V. A review of
research on cost of quality models and best prac-
tices. International Journal of Quality & Reliability
Management, 2006 23(6), 647-669. ht t ps://doi.
org/10.1108/02656710610672470
91. Chenge, M-H and Rosentrater, K. A. Economic
Feasibility Analysis of Soybean Oil Production by
Hexane Extraction. Industrial Crops and Products,
2017. 108, 775-785. https://doi.org/10.1016/j.ind-
crop.2017.07.036
92. Sparling, D. H. and Sterling, B. Food Traceability:
Understanding the Business Value. ResearchGate.
(2014). (accessed July 12, 2021) ht t ps://w w w.re-
searchgate.net/publication/264878496_FOOD_
TRACEABILIT Y_UNDERSTANDING_THE _BUSI-
NESS_VALUE
93. Barosz, P.; Golda, G.; and Kampa, A. Efficiency
A n a ly si s of M a nu f ac t u r i n g L i ne w it h I ndu s-
trial Robots and Human Operators. Applied Sci-
ences, 2020. 10(8), 2862. https://doi.org/10.3390/
app10082862
94. Beauvais, B.; Richter, J. P.; Kim, F. S.; Sickels, G.;
Hook, T.; Kiley, S.; and Horal, T. Does Patient Safety
Pay? Evaluating the Association Between Surgical
Care Improvement Project Performance and Hos-
pital Profitabilit y. Journal of Healthcare Manage-
ment, 2019 64(3), 142-154. http://doi.org/10.1097/
JHM-D-17-00208
